Alternatively, circulating immune cells can be activated, with blood–brain barrier damage after cerebral infarction, promoting the expression of cell adhesion molecules (ICAM-1, VCAM-1) in vascular endothelial cells. This evidence concerns the gene ICAM1 and brain infarction.